ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

AACR 2001 Honorary Awards Announced; Nora Janjan Is ASTRO President-Elect.

January 5, 2001

Six Institutions Get Awards For LAK-IL-2 Trials

February 7, 1986

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984